Original Paper : The Effects of Alendronate Sodium-Cholecalciferol during Osteogenic Differentiation in Mouse Multipotent Bone Marrow Stromal Cells
분야
의약학 > 의공학
저자
( Hyung Keun Kim ) , ( Ji Hyun Kim ) , ( Hye Gwang Jeong ) , ( Myung Ho Jeong ) , ( Taek Rim Yoon )
발행기관
한국조직공학·재생의학회
간행물정보
조직공학과 재생의학 2009년, 제6권 제4호, 520~526페이지(총7페이지)
파일형식
2a800367.pdf [무료 PDF 뷰어 다운로드]
  • ※ 본 자료는 참고용 논문으로 수정 및 텍스트 복사가 되지 않습니다.
  • 구매가격
    4,500원
    적립금
    135원 (구매자료 3% 적립)
    이메일 발송  스크랩 하기
    자료 다운로드  네이버 로그인
    영문초록
    It has been well established that alendronate sodium-cholecalciferol(ASC) inhibits osteoclastic activity, and that this underlies its effectiveness as a treatment for metabolic bone diseases. Moreover, recent studies have indicated that ASC may have other effects on osteoblast activity. In this study, we evaluated the effect of ASC on the osteogenic differentiation of mouse mesenchymal stem cells. Accordingly, D1 cells(multipotent mouse mesenchymal stem cells) were cultured in osteogenic differentiation medium(ODM) for 3 days, and then treated with ASC for 2 days. The cell proliferation was determined using MTT assays, mineralization was followed by staining with alizarin red, alkaline phosphatase activity was measured using a commercial ELISA kit, calcification by energy dispersive X-ray spectrophotometry(EDX), osteogenic gene expression using RT-PCR, and changes in CD 44 expression by confocal microscopy and FACS. D1 cells differentiated into osteoblasts in the presence of ODM, as confirmed by positive Alizarin red S staining, increased ALP activity and osteocalcin mRNA expression, a calcium peak by EDX, and by positive immunofluorescence staining against CD 44(an antigen present on osteoblasts). After ASC had been added to ODM, osteogenic differentiation was enhanced, as confirmed by Alizarin red S staining, elevated ALP activity and osteocalcin mRNA expression, a greater calcium peak by EDX, and by immunofluorescence staining against CD 44 by FACS. This study demonstrates that ASC enhances osteogenic differentiation when treated to mouse mesenchymal stem cells in ODM. The authors suggest that ASC increases bone density by increasing the osteogenic differentiation of mesenchymal stem cells and by inhibiting osteoclast activity.
    사업자등록번호 220-87-87785 대표.신현웅 주소.서울시 서초구 방배로10길 18, 402호 대표전화.070-8809-9397
    개인정보책임자.박정아 통신판매업신고번호 제2017-서울서초-1765호 이메일 help@reportshop.co.kr
    copyright (c) 2009 happynlife. steel All reserved.